PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN Drug Patent Profile
✉ Email this page to a colleague
When do Propoxyphene Napsylate And Acetaminophen patents expire, and what generic alternatives are available?
Propoxyphene Napsylate And Acetaminophen is a drug marketed by Able, Actavis Elizabeth, Cornerstone, Halsey, Ivax Sub Teva Pharms, Mallinckrodt, Mirror Pharms, Mutual Pharm, Mylan, Mylan Pharms Inc, Sandoz, Superpharm, Teva, Vintage Pharms, Watson Labs, Watson Labs Florida, and Wockhardt Ltd. and is included in twenty-six NDAs.
The generic ingredient in PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN is acetaminophen; propoxyphene napsylate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; propoxyphene napsylate profile page.
Summary for PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
US Patents: | 0 |
Applicants: | 17 |
NDAs: | 26 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Patent Applications: | 8 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN at DailyMed |